Michihiro Suzuki
- Hepatology top 1%
- Epidemiology top 10%
- Molecular Biology
- Ophthalmology top 2%
- Surgery
- Co-authors
- Fumio ItohYasuhiro YoshikawaChiaki OkuseHideaki TakahashiHiroki IkedaKeiji TeraoFumiaki ChoShigeo Tsukahara
- Topics
- Liver Disease Diagnosis and Treatment (43 papers)Hepatitis C virus research (32 papers)Hepatitis B Virus Studies (25 papers)
- Cited by
- HepatologyOphthalmologyEpidemiology
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Michihiro Suzuki
115 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Hepatology 559
- Epidemiology 450
- Molecular Biology 381
- Ophthalmology 313
- Surgery 178
Countries citing papers authored by Michihiro Suzuki
This map shows the geographic impact of Michihiro Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michihiro Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michihiro Suzuki more than expected).
Fields of papers citing papers by Michihiro Suzuki
This network shows the impact of papers produced by Michihiro Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michihiro Suzuki. The network helps show where Michihiro Suzuki may publish in the future.
Co-authorship network of co-authors of Michihiro Suzuki
This figure shows the co-authorship network connecting the top 25 collaborators of Michihiro Suzuki. A scholar is included among the top collaborators of Michihiro Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michihiro Suzuki. Michihiro Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 6 | |
| 4 | 27 | |
| 5 | 8 | |
| 6 | 0 | |
| 7 | Stricter Control of Alanine Transaminase by Long-term Administration of Glycyrrhizin Counters the Disease Progression in Patients with Chronic Hepatitis C | 1 |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 44 | |
| 11 | 3 | |
| 12 | 13 | |
| 13 | 4 | |
| 14 | Quantitative Cerebral Blood Flow Calculation Method using Xenon CT : Introduction of a Factor Reflecting Diffusing Capacity of the Lung for Xenon | 1 |
| 15 | 5 | |
| 16 | 1 | |
| 17 | 3 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 7 |
About Michihiro Suzuki
Michihiro Suzuki is a scholar working on Hepatology, Epidemiology and Ophthalmology, having authored 126 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (43 papers), Hepatitis C virus research (32 papers) and Hepatitis B Virus Studies (25 papers). The work is most often cited by research in Hepatology (559 citations), Ophthalmology (313 citations) and Epidemiology (450 citations). Michihiro Suzuki has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Fumio Itoh, Yasuhiro Yoshikawa, Chiaki Okuse, Hideaki Takahashi, Hiroki Ikeda, Keiji Terao, Fumiaki Cho, Shigeo Tsukahara, Kenji Kashiwagi and Hiroshi Yotsuyanagi. Their work appears in journals such as PLoS ONE, Cancer and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.